Invention Grant
- Patent Title: Clec9A binding agents
-
Application No.: US16075318Application Date: 2017-02-06
-
Publication No.: US11001631B2Publication Date: 2021-05-11
- Inventor: Jan Tavernier , Nikolai Kley , Anje Cauwels , Sarah Gerlo
- Applicant: Orionis Biosciences BV , VIB VZW , Universiteit Gent
- Applicant Address: BE Ghent; BE Ghent; BE Ghent
- Assignee: Orionis Biosciences BV,VIB VZW,Universiteit Gent
- Current Assignee: Orionis Biosciences BV,VIB VZW,Universiteit Gent
- Current Assignee Address: BE Ghent; BE Ghent; BE Ghent
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/EP2017/052544 WO 20170206
- International Announcement: WO2017/134301 WO 20170810
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/715 ; C07K16/24 ; A61K38/00 ; A61K39/395 ; C07K16/00 ; C07K14/56 ; A61P35/00 ; A61K39/00
Abstract:
The present invention relates, in part, to agents that bind Clec9A and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the Clec9A binding agents and their use in the treatment of various diseases.
Public/Granted literature
- US20190352406A1 CLEC9A BINDING AGENTS Public/Granted day:2019-11-21
Information query
